Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Gonadotropin peptide |
Is a |
True |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pituitary gonadotropin |
Is a |
True |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human chorionic gonadotropin |
Is a |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chorionic gonadotropin preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chorionic gonadotrophin 1500iu injection (pdr for recon)+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chorionic gonadotrophin 2000iu injection (pdr for recon)+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
choriogonadotropine alfa 5000 UI, ampoule de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chorionic gonadotrophin 10,000iu injection (pdr for recon)+solvent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing recombinant human chorionic gonadotrophin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Urofollitropin (substance) |
Is a |
True |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Gonadotropin preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human menopausal gonadotrophins (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human menopausal gonadotrophins 75units(FSH) powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human menopausal gonadotrophins 75iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human menopausal gonadotrophins 150iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human menopausal gonadotrophins 150units(FSH) injection (pdr for recon)+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human menopausal gonadotrophins 75iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human menopausal gonadotrophins 150iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Choriogonadotropin (substance) |
Is a |
True |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Gonadotropin-releasing hormone analog |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing gonadotropin releasing hormone receptor antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental gonadotrophin poisoning |
Causative agent (attribute) |
True |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional gonadotrophin poisoning |
Causative agent (attribute) |
True |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Gonadotrophin poisoning of undetermined intent |
Causative agent (attribute) |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Gonadotrophic hormone adverse reaction |
Causative agent (attribute) |
True |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to gonadotropin |
Causative agent (attribute) |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Gonadorelin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing ganirelix (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ganirelix 0.25mg/0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing buserelin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Buserelin 1mg/mL injection solution 5.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Buserelin (as buserelin acetate) 100 microgram/actuation nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Goserelin (as goserelin acetate) 3.6 mg prolonged-release subcutaneous implant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 3.75mg powder for injection solution + diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 11.25mg injection (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing triptorelin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triptorelin 4.2mg powder and solvent for injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Gonadotrophic hormone (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing leuprorelin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Buserelin 150micrograms spray (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Histrelin 50mg implant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 45mg powder for injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Goserelin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Goserelin acetate preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing nafarelin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nafarelin acetate preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Histrelin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Histrelin acetate preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing gonadorelin acetate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Gonadorelin hydrochloride preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing gonadotropin releasing factor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning by gonadotropin |
Causative agent (attribute) |
True |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Leuprolide acetate 65mg implant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triptorelin 3.75mg powder and solvent for injection prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triptorelin 15mg powder and dilutent for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Buserelin acetate [endometriosis] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprorelin acetate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Gonadotrophin release hormone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Abarelix-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Abarelix 100mg powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Goserelin acetate 10.8mg injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triptorelin pamoate 3.75mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triptorelin pamoate 11.25mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 15mg powder and solvent for injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 5mg/mL injection solution 0.2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 3.75mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 7.5mg/vial injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 22.5mg injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 30mg/vial injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 11.25mg powder for injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Gonadorelin hydrochloride 100mcg/vial injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Goserelin acetate 3.6mg implant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Histrelin 120mcg/0.6mL (200mcg/mL peptide base) injection solution 0.6mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Histrelin 600mcg/0.6mL (1000mcg/mL peptide base) injection solution 0.6mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Histrelin 300mcg/0.6mL (500mcg/mL peptide base) injection solution 0.6mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to gonadotropin |
Causative agent (attribute) |
True |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Follitropin alfa (substance) |
Is a |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Recombinant human follicle stimulating hormone beta |
Is a |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lutropin alfa (substance) |
Is a |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Recombinant human chorionic gonadotrophin |
Is a |
False |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing gonadotropin (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gonadotropin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |